Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Lamminmäki U[au]:

Role of lectin microarrays in cancer diagnosis. Syed P et al. Proteomics. (2016)

Eph Receptors as Drug Targets: Single-Chain Antibodies and Beyond. Lamminmaki U et al. Curr Drug Targets. (2015)

Rapid and Highly Sensitive Non-Competitive Immunoassay for Specific Detection of Nodularin. Akter S et al. Microorganisms. (2017)

Search results

Items: 1 to 50 of 66

1.

Improvement of Fab expression by screening combinatorial synonymous signal sequence libraries.

Kulmala A, Huovinen T, Lamminmäki U.

Microb Cell Fact. 2019 Sep 16;18(1):157. doi: 10.1186/s12934-019-1210-1.

2.

Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma.

Terävä J, Tiainen L, Lamminmäki U, Kellokumpu-Lehtinen PL, Pettersson K, Gidwani K.

PLoS One. 2019 Jul 25;14(7):e0219480. doi: 10.1371/journal.pone.0219480. eCollection 2019.

3.

A Nanoparticle-Based Approach for the Detection of Extracellular Vesicles.

Islam MK, Syed P, Lehtinen L, Leivo J, Gidwani K, Wittfooth S, Pettersson K, Lamminmäki U.

Sci Rep. 2019 Jul 11;9(1):10038. doi: 10.1038/s41598-019-46395-2.

4.

Noncompetitive Chromogenic Lateral-Flow Immunoassay for Simultaneous Detection of Microcystins and Nodularin.

Akter S, Kustila T, Leivo J, Muralitharan G, Vehniäinen M, Lamminmäki U.

Biosensors (Basel). 2019 Jun 18;9(2). pii: E79. doi: 10.3390/bios9020079.

5.

Development of anti-immunocomplex specific antibodies and non-competitive time-resolved fluorescence immunoassay for the detection of estradiol.

Leivo J, Kivimäki L, Juntunen E, Pettersson K, Lamminmäki U.

Anal Bioanal Chem. 2019 Sep;411(22):5633-5639. doi: 10.1007/s00216-019-01952-6. Epub 2019 Jun 8.

6.

Array-In-Well Epitope Mapping of Phage-Displayed Antibodies.

Lamminmäki U, Batra G, Saviranta P.

Methods Mol Biol. 2018;1785:129-140. doi: 10.1007/978-1-4939-7841-0_9.

PMID:
29714016
7.

Rapid and Highly Sensitive Non-Competitive Immunoassay for Specific Detection of Nodularin.

Akter S, Vehniäinen M, Kankaanpää HT, Lamminmäki U.

Microorganisms. 2017 Sep 12;5(3). pii: E58. doi: 10.3390/microorganisms5030058.

8.

Effect of DNA sequence of Fab fragment on yield characteristics and cell growth of E. coli.

Kulmala A, Huovinen T, Lamminmäki U.

Sci Rep. 2017 Jun 19;7(1):3796. doi: 10.1038/s41598-017-03957-6.

9.

Super-sensitive time-resolved fluoroimmunoassay for thyroid-stimulating hormone utilizing europium(III) nanoparticle labels achieved by protein corona stabilization, short binding time, and serum preprocessing.

Näreoja T, Rosenholm JM, Lamminmäki U, Hänninen PE.

Anal Bioanal Chem. 2017 May;409(13):3407-3416. doi: 10.1007/s00216-017-0284-z. Epub 2017 Mar 16.

10.

Array-in-well binding assay for multiparameter screening of phage displayed antibodies.

Pérez-Gamarra S, Hattara L, Batra G, Saviranta P, Lamminmäki U.

Methods. 2017 Mar 1;116:43-50. doi: 10.1016/j.ymeth.2016.12.004. Epub 2016 Dec 9.

PMID:
27956240
11.

Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis.

Thorek DL, Watson PA, Lee SG, Ku AT, Bournazos S, Braun K, Kim K, Sjöström K, Doran MG, Lamminmäki U, Santos E, Veach D, Turkekul M, Casey E, Lewis JS, Abou DS, van Voss MR, Scardino PT, Strand SE, Alpaugh ML, Scher HI, Lilja H, Larson SM, Ulmert D.

Sci Transl Med. 2016 Nov 30;8(367):367ra167.

12.

Recombinant antibodies for specific detection of clostridial [Fe-Fe] hydrogenases.

Mangayil R, Karp M, Lamminmäki U, Santala V.

Sci Rep. 2016 Oct 27;6:36034. doi: 10.1038/srep36034.

13.

Next generation sequencing of all variable loops of synthetic single framework scFv-Application in anti-HDL antibody selections.

Lövgren J, Pursiheimo JP, Pyykkö M, Salmi J, Lamminmäki U.

N Biotechnol. 2016 Dec 25;33(6):790-796. doi: 10.1016/j.nbt.2016.07.009. Epub 2016 Jul 19.

PMID:
27450754
14.

Broad-Spectrum Noncompetitive Immunocomplex Immunoassay for Cyanobacterial Peptide Hepatotoxins (Microcystins and Nodularins).

Akter S, Vehniäinen M, Spoof L, Nybom S, Meriluoto J, Lamminmäki U.

Anal Chem. 2016 Oct 18;88(20):10080-10087. doi: 10.1021/acs.analchem.6b02470. Epub 2016 Oct 4.

PMID:
27657987
15.

A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources.

Gidwani K, Huhtinen K, Kekki H, van Vliet S, Hynninen J, Koivuviita N, Perheentupa A, Poutanen M, Auranen A, Grenman S, Lamminmäki U, Carpen O, van Kooyk Y, Pettersson K.

Clin Chem. 2016 Oct;62(10):1390-400. doi: 10.1373/clinchem.2016.257691. Epub 2016 Aug 18.

16.

Structural basis for Myf and Psa fimbriae-mediated tropism of pathogenic strains of Yersinia for host tissues.

Pakharukova N, Roy S, Tuittila M, Rahman MM, Paavilainen S, Ingars AK, Skaldin M, Lamminmäki U, Härd T, Teneberg S, Zavialov AV.

Mol Microbiol. 2016 Nov;102(4):593-610. doi: 10.1111/mmi.13481. Epub 2016 Sep 14.

17.

Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris.

Kaushik N, Rohila D, Arora U, Raut R, Lamminmäki U, Khanna N, Batra G.

BMC Biotechnol. 2016 Feb 4;16:12. doi: 10.1186/s12896-016-0243-3.

18.

Role of lectin microarrays in cancer diagnosis.

Syed P, Gidwani K, Kekki H, Leivo J, Pettersson K, Lamminmäki U.

Proteomics. 2016 Apr;16(8):1257-65. doi: 10.1002/pmic.201500404. Epub 2016 Mar 29. Review.

PMID:
26841254
19.

Identification and analysis of anti-HDL scFv-antibodies obtained from phage display based synthetic antibody library.

Negi P, Lövgren J, Malmi P, Sirkka N, Metso J, Huovinen T, Brockmann EC, Pettersson K, Jauhiainen M, Lamminmäki U.

Clin Biochem. 2016 Apr;49(6):472-479. doi: 10.1016/j.clinbiochem.2015.11.020. Epub 2015 Dec 2.

PMID:
26656638
20.

Development of recombinant antibody-based enzyme-linked immunosorbent assay (ELISA) for the detection of skatole.

Leivo J, Mäkelä J, Rosenberg J, Lamminmäki U.

Anal Biochem. 2016 Jan 1;492:27-9. doi: 10.1016/j.ab.2015.09.014. Epub 2015 Sep 26.

PMID:
26410338
21.

Fast conversion of scFv to Fab antibodies using type IIs restriction enzymes.

Sanmark H, Huovinen T, Matikka T, Pettersson T, Lahti M, Lamminmäki U.

J Immunol Methods. 2015 Nov;426:134-9. doi: 10.1016/j.jim.2015.08.005. Epub 2015 Aug 10.

PMID:
26271437
22.

Eph Receptors as Drug Targets: Single-Chain Antibodies and Beyond.

Lamminmaki U, Nikolov D, Himanen J.

Curr Drug Targets. 2015;16(10):1021-30. Review.

PMID:
26028047
23.

Phage display aided improvement of a unique prostate-specific antigen (PSA) antibody unreactive with Lys(145)-Lys(146) internally cleaved forms.

Liton MF, Peltola MT, Vehniäinen M, Kuusela E, Pettersson T, Lamminmäki U, Pettersson K, Brockmann EC.

J Immunol Methods. 2015 Jul;422:72-9. doi: 10.1016/j.jim.2015.04.005. Epub 2015 Apr 15.

PMID:
25889751
24.

GTP-specific fab fragment-based GTPase activity assay.

Kopra K, Rozwandowicz-Jansen A, Syrjänpää M, Blaževitš O, Ligabue A, Veltel S, Lamminmäki U, Abankwa D, Härmä H.

Anal Chem. 2015 Mar 17;87(6):3527-34. doi: 10.1021/acs.analchem.5b00117. Epub 2015 Mar 3.

PMID:
25707436
25.

Generation and characterization of a single-chain anti-EphA2 antibody.

Goldgur Y, Susi P, Karelehto E, Sanmark H, Lamminmäki U, Oricchio E, Wendel HG, Nikolov DB, Himanen JP.

Growth Factors. 2014 Dec;32(6):214-22. doi: 10.3109/08977194.2014.983225. Epub 2014 Nov 19.

26.

Precise construction of oligonucleotide-Fab fragment conjugate for homogeneous immunoassay using HaloTag technology.

Päkkilä H, Peltomaa R, Lamminmäki U, Soukka T.

Anal Biochem. 2015 Mar 1;472:37-44. doi: 10.1016/j.ab.2014.11.018. Epub 2014 Dec 3.

PMID:
25481738
27.

The selection performance of an antibody library displayed on filamentous phage coat proteins p9, p3 and truncated p3.

Huovinen T, Syrjänpää M, Sanmark H, Seppä T, Akter S, Khan LM, Lamminmäki U.

BMC Res Notes. 2014 Sep 19;7:661. doi: 10.1186/1756-0500-7-661.

28.

Lactobacillus helveticus MIMLh5-specific antibodies for detection of S-layer protein in Grana Padano protected-designation-of-origin cheese.

Stuknyte M, Brockmann EC, Huovinen T, Guglielmetti S, Mora D, Taverniti V, Arioli S, De Noni I, Lamminmäki U.

Appl Environ Microbiol. 2014 Jan;80(2):694-703. doi: 10.1128/AEM.03057-13. Epub 2013 Nov 15.

29.

Multiresidue detection of fluoroquinolones: specificity engineering of a recombinant antibody with oligonucleotide-directed mutagenesis.

Leivo J, Lamminmäki U, Lövgren T, Vehniäinen M.

J Agric Food Chem. 2013 Dec 11;61(49):11981-5. doi: 10.1021/jf403715n. Epub 2013 Nov 25.

PMID:
24218986
30.

Two ScFv antibody libraries derived from identical VL-VH framework with different binding site designs display distinct binding profiles.

Huovinen T, Syrjänpää M, Sanmark H, Brockmann EC, Azhayev A, Wang Q, Vehniäinen M, Lamminmäki U.

Protein Eng Des Sel. 2013 Oct;26(10):683-93. doi: 10.1093/protein/gzt037. Epub 2013 Aug 21.

PMID:
23966567
31.

Identification of a novel bacterial outer membrane interleukin-1Β-binding protein from Aggregatibacter actinomycetemcomitans.

Paino A, Ahlstrand T, Nuutila J, Navickaite I, Lahti M, Tuominen H, Välimaa H, Lamminmäki U, Pöllänen MT, Ihalin R.

PLoS One. 2013 Jul 31;8(7):e70509. doi: 10.1371/journal.pone.0070509. Print 2013.

32.

Genetically encoded protease substrate based on lanthanide-binding peptide for time-gated fluorescence detection.

Vuojola J, Syrjänpää M, Lamminmäki U, Soukka T.

Anal Chem. 2013 Feb 5;85(3):1367-73. doi: 10.1021/ac302030q. Epub 2013 Jan 15.

PMID:
23272697
33.

Homogenous M13 bacteriophage quantification assay using switchable lanthanide fluorescence probes.

Lehmusvuori A, Manninen J, Huovinen T, Soukka T, Lamminmäki U.

Biotechniques. 2012 Nov;53(5):301-3. doi: 10.2144/0000113954.

34.

Quantitative PCR detection and improved sample preparation of microcystin-producing Anabaena, Microcystis and Planktothrix.

Hautala H, Lamminmäki U, Spoof L, Nybom S, Meriluoto J, Vehniäinen M.

Ecotoxicol Environ Saf. 2013 Jan;87:49-56. doi: 10.1016/j.ecoenv.2012.10.008. Epub 2012 Nov 2.

PMID:
23122919
35.

A simple heterogeneous one-step assay for screening estrogenic compounds.

Huovinen T, Rytkönen K, Lamminmäki U, Pellinen T.

Biotechnol Lett. 2013 Jan;35(1):47-53. doi: 10.1007/s10529-012-1050-0. Epub 2012 Sep 18.

PMID:
22986538
36.

High-performance closed-tube PCR based on switchable luminescence probes.

Lehmusvuori A, Karhunen U, Tapio AH, Lamminmäki U, Soukka T.

Anal Chim Acta. 2012 Jun 20;731:88-92. doi: 10.1016/j.aca.2012.04.027. Epub 2012 May 1.

PMID:
22652269
37.

Primer extension mutagenesis powered by selective rolling circle amplification.

Huovinen T, Brockmann EC, Akter S, Perez-Gamarra S, Ylä-Pelto J, Liu Y, Lamminmäki U.

PLoS One. 2012;7(2):e31817. doi: 10.1371/journal.pone.0031817. Epub 2012 Feb 15.

38.

Homogeneous single-label biochemical Ras activation assay using time-resolved luminescence.

Martikkala E, Veltel S, Kirjavainen J, Rozwandowicz-Jansen A, Lamminmäki U, Hänninen P, Härmä H.

Anal Chem. 2011 Dec 15;83(24):9230-3. doi: 10.1021/ac202723h. Epub 2011 Nov 18.

PMID:
22098697
39.

Homogeneous detection of avidin based on switchable lanthanide luminescence.

Karhunen U, Rosenberg J, Lamminmäki U, Soukka T.

Anal Chem. 2011 Dec 1;83(23):9011-6. doi: 10.1021/ac2018052. Epub 2011 Nov 9.

PMID:
22070371
40.

Cd-specific mutants of mercury-sensing regulatory protein MerR, generated by directed evolution.

Hakkila KM, Nikander PA, Junttila SM, Lamminmäki UJ, Virta MP.

Appl Environ Microbiol. 2011 Sep;77(17):6215-24. doi: 10.1128/AEM.00662-11. Epub 2011 Jul 15.

41.

Synthetic single-framework antibody library integrated with rapid affinity maturation by VL shuffling.

Brockmann EC, Akter S, Savukoski T, Huovinen T, Lehmusvuori A, Leivo J, Saavalainen O, Azhayev A, Lövgren T, Hellman J, Lamminmäki U.

Protein Eng Des Sel. 2011 Sep;24(9):691-700. doi: 10.1093/protein/gzr023. Epub 2011 Jun 16.

PMID:
21680620
42.

Enhanced error-prone RCA mutagenesis by concatemer resolution.

Huovinen T, Julin M, Sanmark H, Lamminmäki U.

Plasmid. 2011 Oct;66(1):47-51. doi: 10.1016/j.plasmid.2011.03.004. Epub 2011 Mar 29.

PMID:
21453722
43.

Engineering of a broad-specificity antibody: detection of eight fluoroquinolone antibiotics simultaneously.

Leivo J, Chappuis C, Lamminmäki U, Lövgren T, Vehniäinen M.

Anal Biochem. 2011 Feb 1;409(1):14-21. doi: 10.1016/j.ab.2010.09.041. Epub 2010 Nov 4.

PMID:
20920457
44.

Luminescence switching by hybridization-directed mixed lanthanide complex formation.

Karhunen U, Jaakkola L, Wang Q, Lamminmäki U, Soukka T.

Anal Chem. 2010 Jan 15;82(2):751-4. doi: 10.1021/ac9020825.

PMID:
20017568
45.

Oligovalent Fab display on M13 phage improved by directed evolution.

Huovinen T, Sanmark H, Ylä-Pelto J, Vehniäinen M, Lamminmäki U.

Mol Biotechnol. 2010 Mar;44(3):221-31. doi: 10.1007/s12033-009-9231-3.

PMID:
20012710
46.

Resonance energy transfer from lanthanide chelates to overlapping and nonoverlapping fluorescent protein acceptors.

Vuojola J, Lamminmäki U, Soukka T.

Anal Chem. 2009 Jun 15;81(12):5033-8. doi: 10.1021/ac9005793.

PMID:
19438245
47.

Study on nonspecificity of an immuoassay using Eu-doped polystyrene nanoparticle labels.

Näreoja T, Vehniäinen M, Lamminmäki U, Hänninen PE, Härmä H.

J Immunol Methods. 2009 Jun 30;345(1-2):80-9. doi: 10.1016/j.jim.2009.04.008. Epub 2009 Apr 18.

PMID:
19379754
48.

Development of a denaturation/renaturation-based production process for ferritin nanoparticles.

Jääskeläinen A, Soukka T, Lamminmäki U, Korpimäki T, Virta M.

Biotechnol Bioeng. 2009 Mar 1;102(4):1012-24. doi: 10.1002/bit.22140.

PMID:
18958859
49.

Biologically produced bifunctional recombinant protein nanoparticles for immunoassays.

Jääskeläinen A, Harinen RR, Soukka T, Lamminmäki U, Korpimäki T, Virta M.

Anal Chem. 2008 Feb 1;80(3):583-7. doi: 10.1021/ac071382v. Epub 2008 Jan 8.

PMID:
18179181
50.

Production of apoferritin-based bioinorganic hybrid nanoparticles by bacterial fermentation followed by self-assembly.

Jääskeläinen A, Harinen RR, Lamminmäki U, Korpimäki T, Pelliniemi LJ, Soukka T, Virta M.

Small. 2007 Aug;3(8):1362-7. No abstract available.

PMID:
17600800

Supplemental Content

Loading ...
Support Center